Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Operating Income Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual operating income in 2023 was -24.99 Million USD , up 26.46% from previous year.
Medtecs International Corporation Limited's latest quarterly operating income in 2024 Q2 was -6.15 Million USD , up 65.8% from previous quarter.
Medtecs International Corporation Limited reported an annual operating income of -30.07 Million USD in 2022, down -269.57% from previous year.
Medtecs International Corporation Limited reported an annual operating income of 17.73 Million USD in 2021, down -87.01% from previous year.
Medtecs International Corporation Limited reported a quarterly operating income of -22.11 Million USD for 2023 FY, up 26.46% from previous quarter.
Medtecs International Corporation Limited reported a quarterly operating income of -6.5 Million USD for 2023 Q2, up 77.72% from previous quarter.

Annual Operating Income Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Operating Income of Medtecs International Corporation Limited (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	-24.99 Million USD	26.46%
2022	-30.07 Million USD	-269.57%
2021	17.73 Million USD	-87.01%
2020	136.57 Million USD	3497.84%
2019	3.79 Million USD	44.66%
2018	2.62 Million USD	6.36%
2017	2.46 Million USD	-8.93%
2016	2.7 Million USD	-13.28%
2015	3.12 Million USD	95.74%
2014	1.59 Million USD	-35.04%
2013	2.45 Million USD	-24.89%
2012	3.27 Million USD	-5.79%
2011	3.47 Million USD	193.49%
2010	1.18 Million USD	-34.6%
2009	1.8 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-6.15 Million USD	65.8%
2023 FY	-22.11 Million USD	26.46%
2023 Q2	-6.5 Million USD	77.72%
2023 Q4	-18.01 Million USD	-176.95%
2022 Q2	-3.88 Million USD	-48.96%
2022 FY	-30.07 Million USD	-269.57%
2022 Q4	-29.18 Million USD	-651.85%
2021 Q4	-2.6 Million USD	-114.0%
2021 Q2	18.61 Million USD	-80.32%
2021 FY	17.73 Million USD	-87.01%
2020 Q2	41.59 Million USD	2542.5%
2020 Q4	94.61 Million USD	127.48%
2020 FY	136.57 Million USD	3497.84%
2019 Q4	1.57 Million USD	7.73%
2019 Q2	1.46 Million USD	10.18%
2019 FY	3.79 Million USD	44.66%
2018 Q4	1.32 Million USD	2.16%
2018 FY	2.62 Million USD	6.36%
2018 Q2	1.29 Million USD	53.79%
2017 Q4	844 Thousand USD	-48.0%
2017 Q2	1.62 Million USD	114.68%
2017 FY	2.46 Million USD	-8.93%
2016 FY	2.7 Million USD	-13.28%
2016 Q4	756 Thousand USD	-53.51%
2016 Q2	1.62 Million USD	-4.18%
2015 FY	3.12 Million USD	95.74%
2015 Q4	1.69 Million USD	36.09%
2015 Q2	1.24 Million USD	1147.0%
2014 Q2	973 Thousand USD	452.84%
2014 FY	1.59 Million USD	-35.04%
2014 Q4	100 Thousand USD	-89.72%
2013 Q4	176 Thousand USD	-89.24%
2013 FY	2.45 Million USD	-24.89%
2013 Q2	1.63 Million USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	3.27 Million USD	-5.79%
2011 Q2	- USD	0.0%
2011 FY	3.47 Million USD	193.49%
2011 Q4	- USD	0.0%
2010 FY	1.18 Million USD	-34.6%
2010 Q4	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	1.8 Million USD	0.0%

Peer Operating Income Comparison of Medtecs International Corporation Limited

Name	Operating Income	Operating Income Difference
Nang Kuang Pharmaceutical Co., Ltd.	259.91 Million TWD	109.615%
Maxigen Biotech Inc.	149.85 Million TWD	116.677%
SciVision Biotech Inc.	199.63 Million TWD	112.518%
Bionime Corporation	-13.33 Million TWD	-87.345%
Pegavision Corporation	1.98 Billion TWD	101.261%
Visco Vision Inc.	334.7 Million TWD	107.466%